Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Gibb Clarke
AddedFeb 15, 2024
UpdatedMay 31, 2026
Gibb Clarke

Gibb Clarke

Chief Financial Officer, SaNOtize

Crunchbase

Gibb Clarke's Career

SaNOtize
SaNOtize

Vancouver, BC, CA

Chief Financial Officer· C-Level · Executive
Pulsar Vascular
Pulsar Vascular

San Jose, CA, US

Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Gibb Clarke's Career

SaNOtize
SaNOtize
Series B$24M2017Vancouver, BC, CA
Chief Financial Officer· C-Level · Executive

Recent news

SaNOtize Raises $24M in Oversubscribed Series B FinancingFinancial Post · 2022

Similar to SaNOtize

NoxsanoNoxsanoColumbus, OH, USMedical Devicesest. 2016NoxsanoColumbus, OH, US · est. 2016

Noxsano Inc. develops easy-to-use devices and salves for controlled, localized chronic wound treatment.

Series A · $3M9
NoxilizerNoxilizerBaltimore, MD, USSterilization Equipmentest. 2004NoxilizerBaltimore, MD, US · est. 2004

Noxilizer: Providing NO2-based sterilization technology for medical, pharmaceutical, and hospital sectors.

Private Equity · $4.4M16
Hansen PharmaceuticalHansen PharmaceuticalMiami, FL, USNitric Oxideest. 2014Hansen PharmaceuticalMiami, FL, US · est. 2014

Hansen Pharmaceutical: Innovating nitric oxide technology to combat multi-drug resistant organisms.

Seed · $200k6
Nota LabsNota LabsAnn Arbor, MI, USFace Mask Insertsest. 2014Nota LabsAnn Arbor, MI, US · est. 2014

NOTA Labs, a US startup, innovates face mask inserts for optimal viral and bacterial protection.

Series A · $4.2M12
Pulsar Vascular
Pulsar Vascular
Pre-Seed$1.4M72005San Jose, CA, US
Founder

Leadership at Pulsar Vascular

Rob AbramsRob AbramsCEO

Similar to Pulsar Vascular

Traverse VascularTraverse VascularSolana Beach, CA, USMedical Devicesest. 2019Traverse VascularSolana Beach, CA, US · est. 2019

Traverse Vascular: Innovating chronic total occlusions treatment with breakthrough medical devices since 2019.

Pre-Seed · $1.1M1
Euphrates VascularEuphrates VascularSt. Louis, MO, USMedical Devicesest. 2018Euphrates VascularSt. Louis, MO, US · est. 2018

Euphrates Vascular, a St. Louis-based company, innovates magnet-based medical devices for faster vascular disease treatment.

Series A · $9.7M17
PolyVascularPolyVascularHouston, TX, USMedical Devicesest. 2014PolyVascularHouston, TX, US · est. 2014

PolyVascular: Innovating non-surgical, medical-grade polymer valves for transcatheter pulmonary use.

Pre-Seed · $825k13
Vascular ImagingVascular ImagingRancho Cordova, CA, USMedical Devicesest. 2001Vascular ImagingRancho Cordova, CA, US · est. 2001

California-based Vascular Imaging, a biotech firm co-founded by Daniel A. Halpern, develops medical devices.

Seed · $2.4M8

Gibb Clarke's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao

People Similar to Gibb Clarke

Robert ClarkeRobert ClarkeCo-Founder · Kinaset TherapeuticsTaylor HeineckeTaylor HeineckeCo-Founder · BlockyTodd ChamberlainTodd ChamberlainCo-Founder · MedBloxJeff GarzikJeff GarzikCo-Founder & CEO · MetronomeBert RubinskyBert RubinskyCo-Founder · Medical Grade InnovationsJeff McLarenJeff McLarenBoard Member · HealthStream